摘要
近年来,人们对青光眼发病机制的了解不断加深,发现了阿尔茨海默病(AD)和青光眼在发病机制上有多种流行病学和组织学重叠。随着影像技术的不断发展,人们应用PET/CT诊断AD积累了一定的经验,用其研究青光眼的发病机制和作为青光眼的早期诊疗评估方法也在进行研究。然而,目前仍有很多问题需要明晰和探索。本文主要对此无创的影像检查在青光眼的诊疗方面的应用进展进行综述。
With the development of understanding of the pathogenesis of glaucoma, we find that Alzheimer’s disease (AD) and glaucoma have several epidemiological and histological overlaps in pathogenesis in recent years. Appreciation of the characteristics of PET/CT and their role on Alzheimer’s disease evolves with advances of imaging technology. It is also being explored to study the pathogenesis of glaucoma and as an early diagnosis and treatment method of glaucoma, however, quite a few of questions still need to be further clarified and explored. This article mainly reviews the clinical research and application progress of positron imaging agents in glaucoma.
出处
《眼科学》
2020年第4期274-279,共6页
Hans Journal of Ophthalmology
